Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04670874 · ClinicalTrials.gov registry record

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

A clinical trial of Cutaneous Lymphoma, sponsored by City of Hope Medical Center.

Recruiting
Registry status
1,250
Enrollment target
1
Study location

NCT04670874: Recruiting study of Cutaneous Lymphoma, sponsored by City of Hope Medical Center.

NCT04670874 is a study of Cutaneous Lymphoma that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 1,250 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04670874, a study of Cutaneous Lymphoma, is actively recruiting participants, sponsored by City of Hope Medical Center.

RECRUITING
Registry status
1,250 participants
Enrollment target
1
Study location

Study Summary

This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cutaneous lymphomas are a rare type of blood cancers (non-Hodgkin lymphoma) that present in the skin. The information gained from this study, may help researchers improve quality of life in cutaneous lymphoma patients.

Primary Outcome

Skindex-29 domain (symptom, function, and emotion) scores will be summarized by diagnosis group, demographics, disease characteristics, treatment/intervention, and disease response/clinical outcome. Cross-sectional and longitudinal summary of the data will be performed. Descriptive statistics for continuous data (mean, standard deviation, median, range, etc.) will be used to summarize quality of life. Descriptive and summary statistics or continuous and categorical data (counts and percentages)

Conditions Studied

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 1,250 participants
Start Date 2023-08-17
Est. Completion 2034-01-24
City of Hope Medical Center

582 total trials

What NCT04670874 shows while recruiting

NCT04670874 is an observational study that tracks outcomes without assigning an intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Cutaneous Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04670874 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04670874 about?

NCT04670874 is a clinical study titled "Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29". This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cu...

What is the current status of trial NCT04670874?

This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 2023-08-17. Estimated completion is 2034-01-24.

What conditions does trial NCT04670874 study?

This clinical trial studies the following conditions: Cutaneous Lymphoma.

What interventions are being tested in trial NCT04670874?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT04670874?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04670874 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cutaneous Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02743858 · 1,250 participants

    Lymphedema Surveillance Study

  • NCT04807868 · 1,250 participants

    AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

  • NCT05995821 · 1,250 participants

    Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

  • NCT06024395 · 1,250 participants · NA

    A Stepped Care Approach to Treating Dental Fear

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04670874, the US trial registry maintained by the National Library of Medicine. NCT04670874 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.